University Hospital Zurich Under Investigation After Criminal Complaints Filed Over Patient Deaths

Eleven lives lost and a reputation in tatters: the University Hospital Zurich (USZ) now faces a reckoning that shakes the very foundations of Swiss healthcare. The Zurich public prosecutor has officially launched a high-stakes investigation into the hospital’s Clinic for Cardiac Surgery, following explosive criminal complaints filed by the hospital’s own board. This is no mere administrative error; prosecutors are hunting for evidence of involuntary manslaughter, grievous bodily harm by negligence, and the forgery of documents. A specialized strike team of four elite prosecutors—experts in medical law and white-collar crime—has been mobilized to dismantle a web of alleged malpractice. The scale of the investigation is unprecedented for a Swiss medical institution, signaling that the era of institutional immunity is over. As investigators sift through patient records, the city watches a prestigious pillar of its society grapple with the darkest chapter in its modern history. The pursuit of truth is now a legal mandate, and the consequences for those found responsible will be severe.

A staggering 74 excess deaths haunt the corridors of the cardiac surgery department. The 'Oberholzer Report,' a damning independent audit published in early May, revealed that between 2016 and 2020, the clinic performed approximately 4,500 operations. However, the mortality rate during this period didn't just fluctuate—it surged. Statistical models suggest that between 68 and 74 more patients died than would be expected at a facility of this caliber. These are not just numbers; they represent fathers, mothers, and partners who entered the hospital seeking a second chance at life and never returned. The report documents 'serious errors' that occurred over a four-year span, suggesting a systemic failure in oversight and surgical precision. While the hospital has admitted to these failures, the legal system must now determine if these 'errors' cross the line into criminal negligence. The data presents a grim reality: for years, the risks at USZ were significantly higher than the public was led to believe, raising urgent questions about how such a trend could go unnoticed for so long.

Financial gain and patient safety are a volatile mix, and at USZ, the two allegedly collided with disastrous results. Central to the investigation are 11 separate reports concerning the suspected inappropriate use of medical devices. The allegations center on the clinic’s former director, Francesco Maisano, who is accused of using a medical device he helped develop—and from which he allegedly stood to benefit financially. This potential conflict of interest strikes at the heart of medical ethics. Prosecutors are examining whether the choice of equipment was dictated by clinical necessity or by the lure of profit. The board’s decision to file criminal charges regarding 13 specific cases of device usage suggests that the irregularities were not isolated incidents but part of a broader pattern of misconduct. In a system built on trust, the revelation that a surgeon might prioritize a personal invention over established safety protocols is nothing short of scandalous. The investigation will now pivot to the paper trail, seeking to uncover exactly how these devices were approved and utilized in the operating theater.

The silence has finally been broken, but the cost of the truth remains high. In a dramatic reversal of typical institutional defensiveness, USZ CEO Monika Jänicke has publicly thanked the whistleblower whose courage sparked this massive investigation. This gratitude comes as a sharp contrast to the initial treatment of the informant, who was reportedly fired before the scale of the scandal was fully acknowledged. The hospital is now in damage-control mode, attempting to rebuild a culture of transparency from the ashes of this crisis. However, the road to reform is long. With the Zurich public prosecutor warning that the complexity of the case means the investigation 'will take some time,' the hospital faces months, if not years, of legal scrutiny. This case serves as a warning to medical institutions across Switzerland: the 'code of silence' is no longer a viable shield. As the legal process unfolds, the focus must remain on the victims and the urgent need for a healthcare system where safety is guaranteed and accountability is absolute. Switzerland’s medical reputation depends on the rigor of this investigation.